• SPX
  • $5,751.07
  • 0.9 %
  • $51.13
  • DJI
  • $42,352.75
  • 0.81 %
  • $341.16
  • N225
  • $38,635.62
  • 0.22 %
  • $83.56
  • FTSE
  • $8,280.63
  • -0.02 %
  • -$1.89
  • IXIC
  • $18,137.85
  • 1.22 %
  • $219.38
Calliditas Therapeutics AB (publ) (CALT) Competitors

Calliditas Therapeutics AB (publ) (CALT) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$40.00

-$0.04

(-0.1%)

Day's range
$40
Day's range
$43

Calliditas Therapeutics AB (publ) Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
ASND
Ascendis Pharma A/S $142.68 $7.77 B -14.19 879 $266.72 M
CCCC
C4 Therapeutics, Inc. $5.40 $320.64 M -1.97 145 $20.76 M
CELC
Celcuity Inc. $15.04 $501.59 M -5.14 55 $0
COGT
Cogent Biosciences, Inc. $11.09 $802.20 M -3.37 164 $0
CRNX
Crinetics Pharmaceuticals, Inc. $53.14 $3.53 B -11.86 290 $4.01 M
CYTK
Cytokinetics, Incorporated $56.66 $6.05 B -9.78 423 $7.53 M
DBTX
Decibel Therapeutics, Inc. $4.91 $123.37 M -1.93 68 $0
DICE
DICE Therapeutics, Inc. $47.55 $2.27 B -21.91 71 $0
EWTX
Edgewise Therapeutics, Inc. $28.40 $1.65 B -11.47 97 $0
HOWL
Werewolf Therapeutics, Inc. $2.02 $151.66 M -3.17 45 $19.94 M
KDNY
Chinook Therapeutics, Inc. $40.39 $2.71 B -12.47 214 $6.13 M
MOLN
Molecular Partners AG $5.02 $135.05 M -2.03 161 $7.04 M
OPT
Opthea Limited $4.49 $214.34 M -1.04 33 $125,122
PLRX
Pliant Therapeutics, Inc. $11.53 $672.63 M -3.9 166 $1.58 M
PMVP
PMV Pharmaceuticals, Inc. $1.51 $85.40 M -1.26 63 $0
RLYB
Rallybio Corporation $1.13 $61.34 M -0.79 25 $0
TVTX
Travere Therapeutics, Inc. $15.23 $542.80 M -1.32 380 $145.24 M
VTYX
Ventyx Biosciences, Inc. $2.12 $229.83 M -1.01 73 $0
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.